Literature DB >> 20540157

Pericytes and vessel maturation during tumor angiogenesis and metastasis.

Ahmad Raza1, Michael J Franklin, Arkadiusz Z Dudek.   

Abstract

Despite promising results in preclinical and clinical studies, the therapeutic efficacy of antiangiogenic therapies has been restricted by a narrow focus on inhibiting the growth of endothelial cells. Other cell types in the tumor stroma are also critical to the progression of cancer, including mural cells. Mural cells are vascular support cells that range in phenotype from pericytes to vascular smooth muscle cells. Although the role of pericytes and pericyte-like cells in the pathophysiology of cancer is still unclear, evidence indicates that aberrations in pericyte-endothelial cell signaling networks could contribute to tumor angiogenesis and metastasis. The purpose of this review is to evaluate critically recent evidence on the role of pericytes in tumor biology and discuss potential therapeutic targets for anticancer intervention. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20540157     DOI: 10.1002/ajh.21745

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  135 in total

1.  Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a review.

Authors:  Bryan T Oronsky; Jan J Scicinski; Tony Reid; Susan Knox
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

Review 2.  Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent.

Authors:  Nicholas F Dybdal-Hargreaves; April L Risinger; Susan L Mooberry
Journal:  Clin Cancer Res       Date:  2015-04-02       Impact factor: 12.531

3.  Treating hepatocellular carcinoma progression following first-line sorafenib: therapeutic options and clinical observations.

Authors:  A Ruth He; Alec S Goldenberg
Journal:  Therap Adv Gastroenterol       Date:  2013-11       Impact factor: 4.409

4.  Angiogenesis and melanoma - from basic science to clinical trials.

Authors:  Maxine Sylvia Emmett; Daemon Dewing; Rowan Oliver Pritchard-Jones
Journal:  Am J Cancer Res       Date:  2011-08-08       Impact factor: 6.166

Review 5.  Wounds that will not heal: pervasive cellular reprogramming in cancer.

Authors:  Jung S Byun; Kevin Gardner
Journal:  Am J Pathol       Date:  2013-02-22       Impact factor: 4.307

Review 6.  Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Matrix Biol       Date:  2015-04-22       Impact factor: 11.583

7.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

8.  Oxygen-Glucose Deprivation Induces G2/M Cell Cycle Arrest in Brain Pericytes Associated with ERK Inactivation.

Authors:  Wenjie Wei; Zhiyuan Yu; Minjie Xie; Wei Wang; Xiang Luo
Journal:  J Mol Neurosci       Date:  2016-09-24       Impact factor: 3.444

Review 9.  Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.

Authors:  John D Martin; Dai Fukumura; Dan G Duda; Yves Boucher; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

10.  The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems.

Authors:  Min Wu; Hermann B Frieboes; Steven R McDougall; Mark A J Chaplain; Vittorio Cristini; John Lowengrub
Journal:  J Theor Biol       Date:  2012-12-07       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.